Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis

Clinical Orthopaedics and Related Research

Volumn 453, Issue , 2006, Pages 286-292

  Chang, Je Ken ^a,b,c   Ho, Mei Ling ^a,b   Yeh, Ching Hua ^a,b   Chen, Chung Hwan ^a,b,c   Wang, Gwo Jaw ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DEXAMETHASONE; GLUCOCORTICOID; MEVINOLIN; OSTEOCALCIN; PREDNISOLONE; BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADIPOGENESIS; ADULT; BONE DEVELOPMENT; BONE MARROW CELL; BONE NECROSIS; CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOCORTICOID INDUCED OSTEONECROSIS; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ALCOHOLISM; ARTICLE; FEMUR HEAD NECROSIS; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED;

ALCOHOLISM; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DEXAMETHASONE; FEMALE; FEMUR HEAD NECROSIS; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; LOVASTATIN; MALE; MIDDLE AGED; OSTEOCALCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845393117     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000238869.99980.b2     Document Type: Conference Paper

References (35)

1. Arlet J. Nontraumatic avascular necrosis of the femoral head: past, present, and future. Clin Orthop Relat Res. 1992;277:12-21.
2. Centrella M, Rosen V, Wozney JM, Casinghino SR, McCarthy TL. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem. 1997;67:528-540.
3. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054-1063.
4. Cui Q, Wang GJ, Su CC, Balian G. The Otto Aufranc Award: Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res. 1997;344:8-19.
5. Diduch DR, Coe MR, Joyner C, Owen ME, Balian G. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J Bone Joint Surg Am. 1993;75:92-105.
6. Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA. 1960;174:966-971.
7. Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995;15:1858-1869.
8. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754.
9. Farge D, Parfrey PS, St Andre C, Kuo YL, Guttmann RD. Aseptic necrosis following renal transplantation: a 25-year experience. Transplant Proc. 1985;17:1947-1950.
10. Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987;1:902-906.
11. Gohel A, McCarthy MB, Gronowicz G. Estrogen prevents glucocorticoid- induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology. 1999;140:5339-5347.
12. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81-88.
13. Hirota Y, Hirohata T, Fukuda K, Mori M, Yanagawa H, Ohno Y, Sugioka Y. Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am J Epidemiol. 1993;137:530-538.
14. Jones JP Jr. Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res. 1992;277:41-53.
15. Jones JP Jr, Engleman EP, Najarian JS. Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med. 1965;273:1453-1458.
16. Kawai K, Tamaki A, Hirohata K. Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head: a histochemical and electron microscopic study. J Bone Joint Surg Am. 1985;67:755-763.
17. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459-474.
18. Mulliken BD, Renfrew DL, Brand RA, Whitten CG. Prevalence of previously undetected osteonecrosis of the femoral head in renal transplant recipients. Radiology. 1994;192:831-834.
19. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946-1949.
20. Ohzono K, Saito M, Sugano N, Takaoka K, Ono K. The fate of nontraumatic avascular necrosis of the femoral head: a radiologic classification to formulate prognosis. Clin Orthop Relat Res. 1992;277:73-78.
21. Ono K, Tohjima T, Komazawa T. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. Clin Orthop Relat Res. 1992;277:89-97.
22. Parfrey PS, Farge D, Parfrey NA, Hanley JA, Guttman RD. The decreased incidence of aseptic necrosis in renal transplant recipients - a case control study. Transplantation. 1986;41:182-187.
23. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res. 1995;8:137-145.
24. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173-178.
25. Saito S, Ohzono K, Ono K. Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head: the intracapital arterioles. Clin Orthop Relat Res. 1992;277:98-110.
26. Schulte LA, Ludwig W. The venous pattern in femoral head necrosis: digital subtraction angiography and phlebography in 5 patients. Acta Orthop Scand. 1988;59:396-399.
27. Tervonen O, Mueller DM, Matteson EL, Velosa JA, Ginsburg WW, Ehman RL. Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology. 1992;182:845-847.
28. Urbaniak JR, Coogan PG, Gunneson EB, Nunley JA. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting: a long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am. 1995;77:681-694.
29. Vogel G. Cholesterol-lowering drugs may boost bones. Science. 1999;286:1825-1826.
30. Wang GJ, Cui Q, Balian G. The Nicolas Andry award: the pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res. 2000;370:295-310.
31. Wang GJ, Hubbard SL, Reger SI, Miller ED, Stamp WG. Femoral head blood flow in long-term steroid therapy: study of rabbit model. South Med J. 1983;76:1530-1532.
32. Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC. Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res. 1978;130:81-85.
33. Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729-735.
34. Wang Y, Li Y, Mao K, Li J, Cui Q, Wang GJ. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res. 2003;410:213-224.
35. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79:596-604.